CMS Open Payments · Program Year 2024
LNHC, Inc
LNHC, Inc reported $28,695.86 across General Payments, Research, and Ownership to 35 physicians and teaching hospitals across 35 transactions.
- $28.7K Below-median payer
- All-tracks total
- 35 Below-median volume
- Transactions
- 35 Below-median reach
- Recipients
- #1478
- of 1,925 companies
LNHC, Inc reported $28,695.86 across all CMS Open Payments tracks (General + Research + Ownership) to 35 physicians and teaching hospitals in Program Year 2024 - ranking #1478 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $28,695.86, averaging $819.88 per recipient.
How LNHC, Inc's $28.7K all-tracks total breaks down
LNHC, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lnhc-inc LNHC, Inc
$28.7K · #1478/1,925 · 0.0% industry · PY2024
- TOT $28.7K
- RANK #1478
- SHARE 0.0%
- TXN 35
- RCP 35
- CAT 2
- GEN $28.7K
- TOP1 11.6%
- PY 2024
Volume peers
Nearest volume peer: HT Medical, LLC ($28.7K)
LNHC, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for LNHC, Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For LNHC, Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Honoraria" at $28.2K, accounting for 98.2% of this company's General Payments and 14 transactions.
General Payment Breakdown by Type
LNHC, Inc made 2 types of general payments. "Honoraria" is the largest category at $28.2K, 98.2% of General Payments.
How LNHC, Inc divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $28.2K | 14 | 98.2% |
| Food and Beverage | $520.86 | 21 | 1.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $12,722.42 (44.3%) of $28,695.86 in this company's General Payments records across 14 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for LNHC, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Nanette Silverberg
$3,325.54 across 4 reported transactions
- 2
Moise Levy
$2,349.22 across 4 reported transactions
- 3
Dawn Eichenfield
$2,349.22 across 4 reported transactions
- 4
Mercedes Gonzalez
$2,349.22 across 4 reported transactions
- 5
Jeffrey Sugarman
$2,349.22 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
LNHC, Inc's spend rank (#1478 of 1,925, bottom 23% by spend) and concentration rank (#1,142 of 1,838, bottom 38% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Spineart SA : $2.0M total payments, HHI 775
- Theratechnologies Inc. : $330.9K total payments, HHI 772
- LEO Pharma AS : $192.0K total payments, HHI 771
- Axonics, Inc. : $3.0M total payments, HHI 767
- Veracyte, Inc. : $1.3K total payments, HHI 765
- Fosun Pharma USA Inc. : $42.7K total payments, HHI 763
- LNHC, Inc (this company) : $28.7K total payments, HHI 763
- Ipsen Innovation : $349.5K total payments, HHI 763
- Senseonics, Incorporated : $65.4K total payments, HHI 762
- Olympus Corporation of the Americas : $4.7M total payments, HHI 757
- Convergent Dental Inc. : $901.1K total payments, HHI 756
- Cambridge Interventional LLC : $66.1K total payments, HHI 756
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as LNHC, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about LNHC, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with LNHC, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Theragen, Inc.
Alpha Orthopedic Systems
Iterative Scopes, Inc.
Gyder Surgical US Inc
3B Medical, Inc.
Put this to use
LNHC, Inc ranks #1478 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just LNHC, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.